In an April 8 MedPage Today article, Mark Zucker, MD, asked the question as to why there is differential susceptibility to COVID-19 infection. In other words, why do some people become severely ill ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
It's a blood test that measures the amount of glucose-6-phosphate dehydrogenase (G6PD) in your body. G6PD is an enzyme that helps your red blood cells work properly. If your G6PD level is too low, you ...
An observational study recently published in Cancer highlights a notable correlation between glucose-6-phosphate dehydrogenase (G6PD) deficiency and improved clinical outcomes among patients with ...
The FDA has updated the safety labeling for the chemotherapeutic agents capecitabine (Xeloda) and fluorouracil (5-FU) to ...
Complete DPD deficiency markedly impairs 5-FU catabolism, increasing risk of early severe diarrhea, mucositis, neutropenia, ...
The FDA updated its safety labeling for capecitabine and 5-FU to reflect that patients with certain genetic variants risk ...
BRCA To the Future: Platinum Chemotherapy in Biomarker-Selected Metastatic Castrate Resistant Prostate Cancer The following represents disclosure information provided by authors of this manuscript.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results